UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
| $7.52M | ﹤0.01% |
908,165
+15,071
| +2% | +$131K |
|
3377
ChargePoint
CHPT
$158M
| $7.52M | ﹤0.01% |
351,287
+340,959
| +3,301% | +$8.44M |
|
3378
OneSpaWorld
OSW
$2.68B
| $7.51M | ﹤0.01% |
377,516
+12,988
| +4% | +$241K |
|
3379
PUT
Cigna
CI
$73.9B
| $7.51M | ﹤0.01% |
27,200
-7,200
| -21% | -$2.3M |
|
|
NML
3380
Neuberger Energy Infrastructure and Income Fund Inc
NML
$571M
| $7.51M | ﹤0.01% |
850,261
+96,082
| +13% | +$836K |
|
3381
Gentherm
THRM
$1.27B
| $7.51M | ﹤0.01% |
188,036
+6,518
| +4% | +$273K |
|
3382
Atlantic Union Bankshares
AUB
$5.97B
| $7.5M | ﹤0.01% |
197,981
+86,921
| +78% | +$3.44M |
|
3383
iShares JPMorgan EM High Yield Bond ETF
EMHY
$627M
| $7.49M | ﹤0.01% |
197,104
+11,619
| +6% | +$448K |
|
3384
Ocular Therapeutix
OCUL
$1.94B
| $7.49M | ﹤0.01% |
876,546
+191,770
| +28% | +$1.87M |
|
3385
Atmus Filtration Technologies
ATMU
$4.44B
| $7.48M | ﹤0.01% |
190,804
+28,042
| +17% | +$1.14M |
|
3386
iShares US Healthcare Providers ETF
IHF
$1.27B
| $7.47M | ﹤0.01% |
155,729
+13,888
| +10% | +$733K |
|
3387
Talos Energy
TALO
$2.42B
| $7.46M | ﹤0.01% |
767,792
+282,915
| +58% | +$2.98M |
|
|
NARI
3388
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.46M | ﹤0.01% |
146,035
+65,566
| +81% | +$3.22M |
|
3389
PUT
MongoDB
MDB
$31.9B
| $7.45M | ﹤0.01% |
+32,000
| New | +$9.04M |
|
3390
Manchester United
MANU
$3.8B
| $7.45M | ﹤0.01% |
429,311
+132,683
| +45% | +$2.24M |
|
|
SFBS
3391
ServisFirst Bancshares
SFBS
$4.86B
| $7.44M | ﹤0.01% |
87,819
+50,249
| +134% | +$4.46M |
|
3392
PUT
D.R. Horton
DHI
$41.5B
| $7.42M | ﹤0.01% |
53,100
-475,500
| -90% | -$79.5M |
|
3393
Bank of America Series L
BAC.PRL
$3.98B
| $7.42M | ﹤0.01% |
6,086
+2,473
| +68% | +$3.08M |
|
3394
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$99M
| $7.41M | ﹤0.01% |
114,138
+6,965
| +6% | +$459K |
|
3395
RxSight
RXST
$250M
| $7.39M | ﹤0.01% |
215,046
+190,885
| +790% | +$8.61M |
|
3396
Planet Labs
PL
$8.43B
| $7.39M | ﹤0.01% |
1,829,784
+1,628,190
| +808% | +$5.05M |
|
3397
MGP Ingredients
MGPI
$370M
| $7.39M | ﹤0.01% |
187,678
+116,966
| +165% | +$6.36M |
|
3398
PUT
T. Rowe Price
TROW
$24.2B
| $7.38M | ﹤0.01% |
65,300
+10,000
| +18% | +$1.16M |
|
3399
Fortrea Holdings
FTRE
$1.72B
| $7.38M | ﹤0.01% |
395,746
+296,814
| +300% | +$5.78M |
|
3400
Levi Strauss
LEVI
$9.37B
| $7.37M | ﹤0.01% |
425,959
+186,776
| +78% | +$3.31M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.